edgarshade
Bluelighter
Economist
May 24th 2014
With reader comments
As traditional drugs lose their lure, novel ones are filling the gap in the market.
More...
http://www.economist.com/news/inter...ir-lure-novel-ones-are-filling-gap-market-new
May 24th 2014
With reader comments
As traditional drugs lose their lure, novel ones are filling the gap in the market.
“WHEN he first sees her, Raf is sitting on a washing machine about to swallow an eighth of a gram of what is apparently a mixture of speed, monosodium glutamate and an experimental social anxiety disorder medication for dogs.” So begins “Glow”, the latest novel by Ned Beauman, a British author. The scene captures a global reality: in much of the world, traditional mood-altering substances such as cocaine and heroin are in decline. But a pharmacopoeia of synthetic drugs is rapidly taking their place.
Government attempts to crack down on one new drug after another bring to mind a game of whack-a-mole, says one expert. Each new drug brings new harms to users, too. Ketamine has proven far more addictive and physically damaging than ecstasy, and some synthetic cannabinoids have worse side-effects than real cannabis. And though their use still seems to be fairly limited, 52 people in England and Wales died in 2012 after taking new psychoactive substances, up from a handful a few years earlier. That is more than died after taking amphetamines or ecstasy.
In New Zealand, where synthetic drugs are particularly popular, the government has committed itself to testing and regulating new drugs, rather than banning them. So far the practical effect has been to ban all of them, as no testing regime is yet in place, which may be helping the illegal market. But the long-term aspiration is wise. Not all drug-taking is harmful, but trying to stop it has proved extremely so.
More...
http://www.economist.com/news/inter...ir-lure-novel-ones-are-filling-gap-market-new

